What is the disease burden and cost of Venous Thromboembolism (VTE) in Arkansas?

Venous thromboembolism (VTE) is a condition in which a blood clot forms, breaks loose, and lodges elsewhere. It includes both deep vein thrombosis (DVT) and pulmonary embolism (PE).

Total Medicare hospitalization costs with Venous Thromboembolism (VTE) as a primary diagnosis code is $50,382,628 in Arkansas and $5,353,959,067 nationally.
Medicare cost per hospitalization with Venous Thromboembolism (VTE) as a primary diagnosis code is $7,174 in Arkansas and $8,821 nationally.
Medicare cost per 30 day readmission with Venous Thromboembolism (VTE) as a primary diagnosis code is $8,175 in Arkansas and $10,383 nationally.

Venous Thromboembolism (VTE) Incidence Rates

30 Day Readmission Rates with Venous Thromboembolism (VTE)

All Cause 30 Day Readmissions with & without Venous Thromboembolism (VTE) at Index Hospitalization

Average Length of Stay (LOS) with & without Venous Thromboembolism (VTE)

Mortality Rates with & without Venous Thromboembolism (VTE)

Revenue per Day with and without Venous Thromboembolism (VTE)

Medicare Hospitalization & Readmission Costs (Jan 2013 to Dec 2017)

	Total Medicare Inpatient Hospital Hospitalizations ( Venous Thromboembolism (VTE) as a Primary or Secondary Diagnosis )	Total Medicare Inpatient Hospital Payments ( Venous Thromboembolism (VTE) as a Primary or Secondary Diagnosis )	Total Medicare Inpatient Hospital Hospitalizations ( Venous Thromboembolism (VTE) as a Primary Diagnosis )	Total Medicare Inpatient Hospital Payments ( Venous Thromboembolism (VTE) as a Primary Diagnosis )	Medicare Cost per Hospitalization ( Venous Thromboembolism (VTE) as a Primary Diagnosis )	Total Medicare Inpatient Hospital Hospitalizations ( Venous Thromboembolism (VTE) in Hospital )	Total Medicare Inpatient Hospital Payments ( Venous Thromboembolism (VTE) in Hospital )	Total Medicare Inpatient Hospital Hospitalizations when Venous Thromboembolism (VTE) was a Primary or Secondary Diagnosis for 30 Day Readmission	Total Medicare Inpatient Hospital Payments when Venous Thromboembolism (VTE) was a Primary or Secondary Diagnosis for 30 Day Readmission	Total Medicare Inpatient Hospital Hospitalizations when Venous Thromboembolism (VTE) was a Primary Diagnosis for 30 Day Readmission	Total Medicare Inpatient Hospital Payments when Venous Thromboembolism (VTE) was a Primary Diagnosis for 30 Day Readmission	Medicare Cost per 30 Day Readmission when Venous Thromboembolism (VTE) was a Primary Diagnosis for 30 Day Readmission	Total Readmissions with Venous Thromboembolism (VTE) at Index (Primary or Secondary)	Total Readmission Rate with Venous Thromboembolism (VTE) at Index (Primary or Secondary)	Total Readmission Medicare Payments with Venous Thromboembolism (VTE) at Index (Primary or Secondary)	Total Medicare Cost per Readmission with Venous Thromboembolism (VTE) at Index (Primary or Secondary)
National	1,823,417	$31,418,631,335	606,925	$5,353,959,067	$8,821	328,020	$10,977,466,606	452,882	$7,288,607,858	129,155	$1,341,047,191	$10,383	450,523	27.51	$7,469,243,613	$16,579
Arkansas	19,632	$257,667,925	7,022	$50,382,628	$7,174	3,935	$88,721,764	4,737	$62,025,583	1,536	$12,556,852	$8,175	5,147	29.32	$71,724,824	$13,935
Pulaski, AR	2,795	$37,188,691	902	$6,488,404	$7,193	581	$13,695,648	757	$8,524,764	230	$1,799,547	$7,824	849	33.56	$11,068,486	$13,037
Benton, AR	954	$12,649,748	348	$2,723,499	$7,826	140	$3,721,356	213	$2,982,761	68	$634,385	$9,329	217	24.91	$3,417,499	$15,748
Garland, AR	948	$12,898,242	337	$2,535,876	$7,524	168	$4,005,649	259	$3,490,692	72	$617,127	$8,571	242	27.59	$3,310,806	$13,681
Washington, AR	936	$11,281,401	335	$2,108,074	$6,292	177	$3,539,229	213	$2,529,828	71	$468,705	$6,601	222	25.61	$3,174,447	$14,299
Sebastian, AR	737	$11,001,732	219	$1,872,716	$8,551	164	$4,715,139	189	$2,365,279	48	$452,578	$9,428	230	34.02	$3,252,852	$14,142
Craighead, AR	631	$7,346,700	217	$1,496,066	$6,894	140	$2,867,189	127	$1,330,942	41	$314,235	$7,664	191	33.69	$2,329,872	$12,198
Faulkner, AR	590	$6,744,425	203	$1,326,715	$6,535	130	$2,303,569	122	$1,658,755	46	$369,557	$8,033	139	26.73	$1,977,193	$14,224
Jefferson, AR	583	$8,343,925	198	$1,685,112	$8,510	113	$2,499,203	127	$1,782,475	40	$370,438	$9,260	149	29.04	$1,863,532	$12,506
White, AR	568	$6,490,826	221	$1,597,177	$7,227	80	$1,524,211	186	$2,276,378	58	$512,037	$8,828	146	28.08	$1,948,736	$13,347
Saline, AR	444	$5,649,369	158	$1,139,671	$7,213	67	$1,803,174	119	$1,296,208	39	$309,665	$7,940	120	29.7	$1,523,612	$12,696

Dexur MethodologyBack to Top

Data Source: Dexur sourced raw anonymized claims data from Medicare and then performed quality outcomes analysis based on ICD codes specific to the disease / condition.

Disease Incidence Rate: Number of hospitalizations with disease as a percentage of total hospitalizations. In hospital incidence rates are when the disease / condition is developed within the hospital and was not present at the time of admission.

All Cause 30 Day Readmissions with Venous Thromboembolism (VTE) at Index Hospitalization: Rate of patients readmitted to the hospital within 30 days (to any hospital) for any cause when a specific condition was present at time of Hospitalization (Index Hospitalization). All Cause 30 Day Readmission rates are also calculated separately when the disease was present on the hospitalization and without it.

30 Day Readmission Rates with Disease: Rate Number of patients readmitted to the hospital within 30 days (to any hospital) for that specific disease.

Average Length of Stay (LOS): The sum of total days across all stays divided by total stays / hospitalizations. Avg. LOS is also calculated separately when the disease was present on the hospitalization and without it.

Mortality Rate: Percent of patients who expire in hospital. Mortality rates are also calculated separately when the disease was present on the hospitalization and without it.

Revenue per Day: The sum of payments divided by the total number of patient-days in hospital. Revenue per day is also calculated separately when the disease was present on the hospitalization and without it.